ACS Med Chem Lett on Twitter: "The May issue is here with cover art by Stratikos and colleagues who obtained the high-resolution crystal structure of endoplasmic reticulum aminopeptidase 1 with a bound
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity | ACS Medicinal Chemistry Letters
PDF) Probing the Binding Site of Bile Acids in TGR5
Balanced Intersystem Crossing in Iodinated Silicon-Fluoresceins Allows New Class of Red Shifted Theranostic Agents,ACS Medicinal Chemistry Letters - X-MOL
CBD: A New Hope?,ACS Medicinal Chemistry Letters - X-MOL
Supramolecular Hyaluronic Assembly with Aggregation-Induced Emission Mediated in Two Stages for Targeting Cell Imaging | ACS Medicinal Chemistry Letters
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors | ACS Medicinal Chemistry Letters
![Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.8b00410/asset/images/acsmedchemlett.8b00410.social.jpeg_v03 "Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents | ACS Medicinal Chemistry Letters")
Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents | ACS Medicinal Chemistry Letters
ACS Med Chem 2011 (2) 919-923
ACS Med Chem Lett on Twitter: "Our new issue is out with cover art depicting the mechanism of action of vorasidenib (AG-881), a dual inhibitor of mutant IDH1 and 2 for the
Michele on Twitter: "Our article has been awarded the Front Cover in ACS Medicinal Chemistry Letters | Vol 11, No 12 https://t.co/djgtbhA0vI. A special thanks to my mentor @mlbolognesi and all her
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity | ACS Medicinal Chemistry Letters
Featured Letter in ACS Medicinal Chemistry Letters | NITSCHE LAB
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters - X-MOL
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
ACS Med Chem Lett en Twitter: "The new issue is out with cover art by Janda and colleagues @scrippsresearch whose Featured Letter reports the synthesis and in vivo evaluation of cocaine vaccines:
ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
ACS Medicinal Chemistry Letters Referencing Guide ·ACS Medicinal Chemistry Letters citation · Citationsy
ACS Med Chem Lett on Twitter: "The first issue of the year is out with cover art by Vincent Sol and colleagues @unilim and @Univ_Lorraine who report their lysine analogue of Lysine
ACS Med Chem Lett on Twitter: "Updates from ACS Medicinal Chemistry Letters can now be found at @ACSBioMed. Follow us there for news from ACS's portfolio of biomedical journals! https://t.co/fRT2QqqPad" / Twitter
Triazolopyrimidines and Imidazopyridines: Structure–Activity Relationships and in Vivo Efficacy for Trypanosomiasis | ACS Medicinal Chemistry Letters
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance.,ACS Medicinal Chemistry Letters - X-MOL
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases | ACS Medicinal Chemistry Letters
Establishing the Structure-Activity Relationship of Daptomycin.,ACS Medicinal Chemistry Letters - X-MOL
File:Logo of ACS Medicinal Chemistry Letters.svg - Wikimedia Commons
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2 Type X (sPLA2-X) Inhibitors.,ACS Medicinal Chemistry Letters - X-MOL
